Phase 2b/3 Trial of NuSepin® in COVID-19 Pneumonia Patients

NCT05352347 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

1134

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Pneumonia

Interventions

DRUG: NuSepin® 0.2 mg/kg
DRUG: NuSepin® 0.4 mg/kg
DRUG: Placebo

Sponsor

Shaperon